Beigene Ltd (NASDAQ:BGNE)
| 303.05 Delayed Data As of Oct 21 |  +2.67 / +0.89%Today’s Change | 118.55 Today|||52-Week Range 322.98 | +82.82% Year-to-Date |
Latest BGNE News | Press Releases
No recent news for Beigene Ltd.
Today’s Trading
| Previous close | 299.90 |
| Today’s open | 300.00 |
| Day’s range | 300.00 - 305.41 |
| Volume | 154,372 |
| Average volume (3 months) | 270,394 |
| Market cap | $28.7B |
Data as of 4:00pm ET, 10/21/2020
Growth & Valuation
| Earnings growth (last year) | -30.32% |
| Earnings growth (this year) | +0.50% |
| Earnings growth (next 5 years) | +24.00% |
| Revenue growth (last year) | +116.59% |
| P/E ratio | NM |
| Price/Sales | 23.21 |
| Price/Book | 20.28 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| TEVATeva Pharmaceutical | +0.34 | +3.72% |
| BBIOBridgeBio Pharma Inc | -0.18 | -0.46% |
| ---- |
Data as of 4:00pm ET, 10/21/2020
Financials
| Next reporting date | November 5, 2020 |
| EPS forecast (this quarter) | -$4.12 |
| Annual revenue (last year) | $428.9M |
| Annual profit (last year) | -$950.3M |
| Net profit margin | -221.53% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Beijing, Beijing |
Forecasts
